358 related articles for article (PubMed ID: 25070525)
1. Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach.
Nofal A; Nofal E; Yosef A; Nofal H
Int J Dermatol; 2015 Jun; 54(6):667-71. PubMed ID: 25070525
[TBL] [Abstract][Full Text] [Related]
2. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
[TBL] [Abstract][Full Text] [Related]
3. Two-year experience of using the measles, mumps and rubella vaccine as intralesional immunotherapy for warts.
Na CH; Choi H; Song SH; Kim MS; Shin BS
Clin Exp Dermatol; 2014 Jul; 39(5):583-9. PubMed ID: 24934912
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the efficacy and safety of intralesional measles, mumps, and rubella vaccine versus intralesional vitamin D3 for the treatment of warts in children.
Mohta A; Kushwaha RK; Gautam U; Sharma P; Nyati A; Jain SK
Pediatr Dermatol; 2020 Sep; 37(5):853-859. PubMed ID: 32681688
[TBL] [Abstract][Full Text] [Related]
5. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study.
Shaheen MA; Salem SA; Fouad DA; El-Fatah AA
Dermatol Ther; 2015; 28(4):194-200. PubMed ID: 25847793
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recalcitrant warts with Bacillus Calmette-Guérin: a promising new approach.
Nofal A; Yosef A; Salah E
Dermatol Ther; 2013; 26(6):481-5. PubMed ID: 24552412
[TBL] [Abstract][Full Text] [Related]
7. Intralesional injection of Candida albicans antigen versus measles, mumps, and rubella vaccine for treatment of plantar warts.
Rageh RM; Hewedy ES; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):1-5. PubMed ID: 33765749
[TBL] [Abstract][Full Text] [Related]
8. Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional
Nofal A; El-Arab RE; Nasr M; Alakad R
J Cutan Med Surg; 2021; 25(4):377-383. PubMed ID: 33533654
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of autoimplantation therapy and intralesional injection of MMR vaccine in warts treatment.
ElGhareeb MI
Dermatol Ther; 2019 Nov; 32(6):e13135. PubMed ID: 31648401
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Intralesional
Zayan H; Hosny AH; Mamdouh MM; Tawfik YM
J Cutan Med Surg; 2024; 28(3):253-258. PubMed ID: 38497287
[TBL] [Abstract][Full Text] [Related]
11. Intralesional Antigen Immunotherapy in the Treatment of Periungual Warts.
Nofal A; Alakad R; Fouda I; Fawzy MM
J Cutan Med Surg; 2021; 25(3):286-292. PubMed ID: 33504211
[TBL] [Abstract][Full Text] [Related]
12. Comparative study between intralesional injection of MMR, BCG, and candida albicans antigen in treatment of multiple recalcitrant warts.
Eldahshan RM; Ashry WMO; Elsaie ML
J Cosmet Dermatol; 2022 Mar; 21(3):1120-1126. PubMed ID: 34998000
[TBL] [Abstract][Full Text] [Related]
13. Intralesional Measles, Mumps, Rubella Vaccine versus Tuberculin Purified Protein Derivative Injections in the Treatment of Palmoplantar and Periungual Warts: A Double-Blind Randomized Controlled Trial.
Rutnin S; Namasondhi A; Pomsoong C; Kositkuljorn C; Anuntrangsee T; Thadanipon K
Dermatology; 2023; 239(1):109-115. PubMed ID: 36282051
[TBL] [Abstract][Full Text] [Related]
14. Intralesional immunotherapy of common warts: successful treatment with mumps, measles and rubella vaccine.
Nofal A; Nofal E
J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1166-70. PubMed ID: 20202055
[TBL] [Abstract][Full Text] [Related]
15. Intralesional immunotherapy for the treatment of anogenital warts in pediatric population.
Nofal A; Alakad R
J Dermatolog Treat; 2022 Mar; 33(2):1042-1046. PubMed ID: 32703042
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Efficacy of Intralesional Measles, Mumps, and Rubella Vaccine with Intralesional Vitamin D3 as Immunotherapies in the Treatment of Recalcitrant Cutaneous Warts in Adult- A Randomized Placebo-Controlled Study.
Mohta A; Kushwaha RK; Agrawal A; Sharma MK; Gautam U; Jain SK
Indian Dermatol Online J; 2021; 12(6):879-887. PubMed ID: 34934726
[TBL] [Abstract][Full Text] [Related]
17. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Efficacy of Intralesional Purified Protein Derivative (PPD) Versus Intralesional Measles, Mumps, and Rubella (MMR) Vaccine in Management of Multiple Viral Warts.
Bhalala KB; Poojary S; Shah KS
J Cutan Aesthet Surg; 2021; 14(4):397-403. PubMed ID: 35283602
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of intralesional tuberculin protein purified derivative (PPD) and intralesional measles, mumps, rubella (MMR) vaccine for multiple resistant warts.
Mohammed YF; Ibrahim HS; Elbarbary MA; Elsaie ML
J Cosmet Dermatol; 2021 Mar; 20(3):868-874. PubMed ID: 33118675
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guerin Immunotherapy for Recurrent Multiple Warts: An Open-Label Uncontrolled Study.
Jaisinghani AK; Dey VK; Suresh MS; Saxena A
Indian J Dermatol; 2019; 64(2):164. PubMed ID: 30983619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
